Quick Answer
Instil Bio, Inc. reported Net Income of -$71.37 million for fiscal year 2025.
Instil Bio, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$71.37M | +3.7% |
| 2024 | -$74.14M | +52.5% |
| 2023 | -$156.09M | +30.1% |
| 2022 | -$223.18M | -42.3% |
| 2021 | -$156.79M | -315.5% |
| 2020 | -$37.74M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$13.59M | +41.0% | +36.5% |
| June 30, 2025 | -$21.39M | -43.4% | +24.1% |
| March 31, 2025 | -$28.20M | -16.0% | -22.5% |
| September 30, 2024 | -$23.02M | +65.9% | -54.3% |
| June 30, 2024 | -$14.92M | +20.1% | +38.6% |
| March 31, 2024 | -$24.30M | +57.4% | +64.0% |
| September 30, 2023 | -$67.43M | -19.9% | -261.3% |
| June 30, 2023 | -$18.66M | +68.4% | +67.3% |
- Instil Bio, Inc. showed an increase of +3.7% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Instil Bio, Inc.’s net income has declined by 89.1% (from -$37.74 million to -$71.37 million).
- The most recent figure is from Instil Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: